Searches both Title and Fulltext content
Takes you to the requested Key Event
Clear Search Terms Clears search terms and filters

Showing 601 to 625 of 1781 Key Events

Clear Table Filters
ID Title Event Component Count Biological Organization Created At Last Updated AOPs
1026 Increased Apoptosis, Adenomas/carcinomas (follicular cell)
2 Tissue Nov 29, 2016 Sep 16, 2017 None
1027 , Learning and memory, impairment
0 Nov 29, 2016 Nov 29, 2016 None
1028 Activation of specific nuclear receptors, PPAR-gamma activation
1 Molecular Nov 29, 2016 Sep 16, 2017
1029 Increased, adipogenesis
1 Cellular Nov 29, 2016 Sep 16, 2017 163: PPARgamma activation leading to sarcomas in rats, mice, and hamsters
1030 Increased,
0 Nov 29, 2016 Nov 29, 2016 None
1031 Increased, release of growth factors
0 Nov 29, 2016 Nov 29, 2016 None
1032 Increased, secretion of local growth factors
1 Cellular Nov 29, 2016 Sep 16, 2017
1033 Increased, proliferation of mesenchymal cells
1 Cellular Nov 29, 2016 Sep 16, 2017 163: PPARgamma activation leading to sarcomas in rats, mice, and hamsters
1034 Increased, IGF-1 (mouse)
1 Cellular Nov 29, 2016 Sep 16, 2017 163: PPARgamma activation leading to sarcomas in rats, mice, and hamsters
1035 Increased, Firbrosarcoma
1 Tissue Nov 29, 2016 Sep 16, 2017 163: PPARgamma activation leading to sarcomas in rats, mice, and hamsters
1036 Increased, liposarcoma
1 Tissue Nov 29, 2016 Sep 16, 2017 163: PPARgamma activation leading to sarcomas in rats, mice, and hamsters
1037 Increased, hemagiosarcoma
1 Tissue Nov 29, 2016 Sep 16, 2017 163: PPARgamma activation leading to sarcomas in rats, mice, and hamsters
1038 Activation, beta-2 adrenergic receptor
1 Molecular Nov 29, 2016 Sep 16, 2017 164: Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse
1039 Increased activity, beta-2 adrenergic receptor
1 Molecular Nov 29, 2016 Sep 16, 2017 164: Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse
1040 relaxation, smooth muscle
1 Tissue Nov 29, 2016 Dec 3, 2016 164: Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse
1041 Proliferation, smooth muscle
0 Nov 29, 2016 Nov 29, 2016 None
1042 Proliferation/Clonal Expansion, smooth muscle
1 Cellular Nov 29, 2016 Sep 16, 2017 164: Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse
1043 Hypertrophy/hyperplasia, smooth muscle
1 Cellular Nov 29, 2016 Dec 3, 2016 164: Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse
1044 Promotion, mesovarian leiomyomas
1 Tissue Nov 29, 2016 Sep 16, 2017 164: Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse
1045 Decreased, Ovarian E2
1 Tissue Nov 29, 2016 Sep 16, 2017 165: Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse
1046 Suppression, Estrogen receptor (ER) activity
1 Molecular Nov 29, 2016 Feb 28, 2022
1047 Increased, secretion of GnRH from hypothalamus
1 Cellular Nov 29, 2016 Sep 16, 2017
1048 Increased, secretion of leutenizing hormone
0 Nov 29, 2016 Nov 29, 2016 None
1049 Increased, secrection of FSH from anterior pituitary
1 Cellular Nov 29, 2016 Dec 3, 2016 165: Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse
1050 Increased, secretion of LH from anterior pituitary
1 Cellular Nov 29, 2016 Dec 3, 2016